- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/18 - Sulfur atoms
Patent holdings for IPC class C07D 237/18
Total number of patents in this class: 87
10-year publication summary
2
|
3
|
2
|
6
|
2
|
8
|
2
|
8
|
3
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Lario Therapeutics Ltd | 12 |
5 |
Sumitomo Chemical Company, Limited | 9027 |
4 |
Takeda Pharmaceutical Company Limited | 2707 |
4 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2147 |
4 |
FMC Corporation | 848 |
4 |
Inflazome Limited | 85 |
4 |
F. Hoffmann-La Roche AG | 7932 |
3 |
Centre National de La Recherche Scientifique | 10395 |
3 |
Board of Regents, The University of Texas System | 5760 |
3 |
Ecole Pratique des Hautes Etudes | 36 |
3 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2791 |
3 |
Universite de Montpellier | 979 |
3 |
Universite de Strasbourg | 674 |
3 |
KPC Pharmaceuticals, Inc. | 25 |
3 |
Shanghai Kunheng Pharma-tech Co., Ltd | 9 |
3 |
Syngenta Participations AG | 1908 |
2 |
Syngenta Crop Protection AG | 6045 |
2 |
Hinova Pharmaceuticals Inc. | 94 |
2 |
Hoffmann-La Roche Inc. | 3400 |
1 |
The Regents of the University of California | 19859 |
1 |
Other owners | 27 |